BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $15 to $13.
BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.